主任医师、医学博士、博士研究生导师，南方医院神经外科脑胶质瘤专业医疗组组长。目前担任如下学术任职：中国胶质瘤协助组 副组长；中国医师协会胶质瘤专委会委员、中国医师协会胶质瘤专委会手术及相关技术学组委员、广东省医学会神经肿瘤分会青年副主任委员、广东省医学会神经外科分会青年委员、广东省医师协会神经外科委员会委员

胶质瘤治疗抵抗、新型药物靶点筛选

1. Yi GZ^#, Huang GL^#, Guo M, Zhang X, Wang H, Deng S, Li Y, Xiang W, Chen Z, Pan J, Li Z, Yu L, Lei B, Liu Y*, Qi S*. Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2. Brain. 2019;142(8):2352-2366.（1区；IF 15.255）
2. Xie MY, Huang GL*, Lin ZY, Sun XF, Wu CC, Liu YW, Liu LY*, Zeng EY. Insufficient evidence to link human exposure to heavy metals with biomarkers of glioma. J Hazard Mater. 2023;447:130779. （1区；IF 14.224）
3. Qu S^#, Qi S^#, Zhang H^#, Li Z, Wang K, Zhu T, Ye R, Zhang W, Huang GL*, Yi GZ*. Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis. J Exp Clin Cancer Res. 2023;42(1):285. （1区；IF 11.3）
4. Ni B^#, Huang GL^#, Yang R, Wang Z, Song H, Li K, Zhang Y, Wu K, Shi G, Wang X, Shen J*, Liu Y*. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression. J Neuroinflammation. 2023;20(1):80.（1区；IF 9.587）
5. Xie MY, Lin ZY, Liu LY, Wu CC, Liu YW, Huang GL*, Zeng EY*. Use of glioma to assess the distribution patterns of perfluoroalkyl and polyfluoroalkyl substances in human brain. Environ Res. 2022;204(Pt A):112011.（1区；IF 8.431）
6. Que T^#, Zheng H^#, Zeng Y^#, Liu X, Qi G, La Q, Liang T, Li Z, Yi G, Zhang S, Li J, Nie J, Tan JE*, Huang GL*. HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas. Cell Death Dis. 2021;12(12):1147.（2区；IF 9.685）
7. Li K^#, Huang GL^#, Wang Z, Yang R, Zhang W, Ni B, Guan J, Yi G, Li Z, Zhu Q, Peng Q, Yang L, Qi L*, Liu Y*. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4. Biochim Biophys Acta Mol Basis Dis. 2023;1869(1):166571.（2区；IF 6.663）